Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02921503 · ClinicalTrials.gov registry record · NA

Topical Corticosteroid App

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT02921503 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02921503, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

The study aims to evaluate the effectiveness of a mobile application to assist in the prescription of topical corticosteroids (TCS), focusing on best fit choices of potency, vehicle and volume. The mobile application will be developed from the results obtained in a systematic literature review and quality assessment of clinical practice guidelines for topical corticosteroid use. The quality of the guidelines will be assessed using the AGREE II tool. After the app user enters in information concerning patients' rash location and desired treatment duration, the app will generate a list of recommended topical steroids (focusing on specific quantity and potency) for the patient's particular area of need. The objective of the study is to evaluate whether the use of a standardized application will change prescribing practices for primary care physicians, physician assistants and nurse practitioners.

Interventions

  • OTHER mobile topical corticosteroid app

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2017-06-05
Est. Completion 2018-06-01
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT02921503

The ClinicalTrials.gov registry entry for NCT02921503 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which mobile topical corticosteroid app is the first listed.

NCT02921503 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02921503 about?

NCT02921503 is a clinical study titled "Topical Corticosteroid App". The study aims to evaluate the effectiveness of a mobile application to assist in the prescription of topical corticosteroids (TCS), focusing on best fit choices of potency, vehicle and volume. The mobile application will be developed from the results obtained in a systematic literature review and q...

What is the current status of trial NCT02921503?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2017-06-05. Estimated completion is 2018-06-01.

What interventions are being tested in trial NCT02921503?

The interventions under investigation include: mobile topical corticosteroid app (OTHER).

Who is sponsoring clinical trial NCT02921503?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.